Tonix Pharmaceuticals (TNXP) Stock Surges 15% on Patent News
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
While Tonix Pharmaceuticals has been embattled this year, a critical patent issuance for one of its drugs has bolstered TNXP stock.
The post Tonix Pharmaceuticals (TNXP) Stock Surges 15% on Patent News appeared first on InvestorPlace.
More From InvestorPlace